Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Interim Report January-June 2020

“Our office business remains stable and we are seeing a positive trend in retail” says Annica Ånäs, CEO of Atrium Ljungberg.· Net sales increased to SEK 1,464 million (SEK 1,358 m), of which rental income amounted to SEK 1,227 million (SEK 1,280 m). · The letting rate was 92 per cent (93%), including project properties. · Net letting amounted to SEK -7 million (SEK 19 m), of which SEK -1 million (SEK -1 m) referred to project properties. · The operating surplus from property management amounted to SEK 811 million(SEK 879 m). The surplus ratio amounted to 66 per cent (69%). ·

Skanska upgrades railway track in Brno, Czech Republic, for CZK 1.5 billion, about SEK 610 M

Skanska has, together with Electrification of Railways in Prague, signed a contract with The Railway Administration of the Czech Republic to upgrade of an 8.5 kilometer long railway track in Brno, Czech Republic. Skanska’s part of the contract is worth CZK 1.5 billion, about SEK 610 M, which will be included in the order bookings for Europe for the third quarter 2020.Skanska is responsible for a complete upgrade of the infrastructure, pre-electrification adjustments, to make the track more environmentally friendly, and for doubling part of the track. Moreover, Skanska will build two brand

In the starting blocks for heart preservation and PrimECC trial

SECOND QUARTER 2020 (APRIL-JUNE) Financial information · Net sales of non-durable goods in the quarter amounted to SEK 28.0 (50.5) million, corresponding to a decrease of 44 percent in SEK and 46 percent in local currency. Total net sales (incl. durable goods) in the quarter amounted to SEK 30.4 (56.4) million, corresponding to a decrease of 46 percent in SEK and 47 percent in local currency. The Covid-19 pandemic has had a large impact on the sales and product mix during the quarter. The Covid-19 pandemic has resulted in a decrease of lung transplants since intensive Care units

Selvaag Bolig ASA: Purchase of treasury shares

Selvaag Bolig ASA purchased 23 765 treasury shares on 9 July 2020. The shares were purchased at an average price of price of NOK 54.5162. The shares were purchased for the company's share programmes for employees. After the transaction, Selvaag Bolig owns 463 415 treasury shares.  Further information fromSverre Molvik, CFO, Selvaag Bolig ASATelephone: +47 401 00 585, e-mail: smo@selvaagbolig.no   Selvaag Bolig ASA is a residential property developer which controls the entire value chain from acquisition of land to sale of turnkey homes. The company has several thousand

Q-FREE – SECOND QUARTER AND FIRST HALF 2020 RESULTS

Q-Free reports strong second quarter results with significant year-on-year and quarter-on-quarter profitability gains. Swift implementation of cost reduction measures and increased sale of high margin software solutions were the main reasons for the improvements. Another key achievement in the quarter was the increase in available credit and cash at hand. This was fueled by strong cash flow from operations in combination with new debt and equity financing. -We are very pleased with the strong operational performance in the second quarter and how the organization has responded to the

Sedana Medical announces positive top line result in pivotal IsoConDa study

Sedana Medical AB (publ) (SEDANA: FN Stockholm) today announced a positive top line result for the company's pivotal phase III study, IsoConDa. The study reached its primary endpoint; to show that IsoConDa (isoflurane), administered with AnaConDa, is an effective sedation method, for ventilator-intensive care patients, which is non-inferior to propofol. Secondary endpoints are under analysis and will be published together with the primary endpoint in a scientific journal after peer-review. The results indicate that IsoConDa is an effective and safe sedation method and will form the basis for

Sinch AB (publ): Invitation to conference call and web presentation of Sinch Q2 2020 quarterly report

Stockholm, Sweden – Sinch AB (publ) – XSTO: SINCH Sinch AB will publish its Q2 2020 quarterly report on Friday, July 17, 2020, at 07:30 AM CET. You are invited to participate in a conference call at 14:00 AM CEST on the same day. Oscar Werner, CEO, and Roshan Saldanha, CFO, will present the report and review the results. Time for publication of the interim report Friday July 17, 2020, at 07:30 AM CET Time for conference call and web presentation Friday July 17, 2020, at 14:00 AM CET Dial-in numbers and access code Please make sure you are connected to the phone

EQT Infrastructure enters into a new Scheme Implementation Agreement with Metlifecare

· APVG, an entity owned by EQT Infrastructure has entered into a new Scheme Implementation Agreement to acquire 100 percent of Metlifecare’s shares · The transaction consideration of NZD 6.00 per share gives a total consideration of approximately NZD1.3 billion · Metlifecare’s largest shareholder, NZ Super, which holds 19.86 percent of Metlifecare’s shares, has committed to vote in favor of the Scheme · Metlifecare and APVG have agreed to discontinue the court litigation and settle all disputes in respect of the previous SIA Asia Pacific Village Group Limited (“APVG”), an entity

Aptahem enters a collaboration with University Health Network in Canada to test Apta-1 in a coronavirus model

Aptahem (publ) today announced the beginning of a collaboration with the University Health Network, a research hospital affiliated with University of Toronto in Canada. The collaboration aims to evaluate the anti-coagulant Apta-1 as an inhibitor of hyper inflammatory response and an inducer of tissue repair to potentially treat COVID-19 disease.The research team in Canada, led by Professor Mingyao Liu, has developed a unique murine coronavirus-induced acute lung injury model to study SARS with pathological features shared between SARS and COVID-19. This is the only in vivo model of its kind

Bioservo signs distribution agreement with CAS in the UK

Bioservo Technologies AB has signed a distribution agreement with CAS Assembly Tooling and Services for selling Ironhand® in the United Kingdom. CAS Assembly Tooling and Services are a market leader in supplying, installing and servicing production tooling. As well as supplying tooling, they have 20 years’ experience in project management of turnkey assembly facilities for some of the largest manufacturing companies based in the UK and Europe. For many of their clients, they aid them with everything from initial tooling installation to full process control. “In UK there are many

NPRO: 2Q 2020 - influenced by corona and the acquisition of Veidekke Eiendom

Operating revenues ended at NOK 630 million for the quarter, of which NOK 172 million was rental income, while sales revenues from the residential project at Hasle in Oslo came to NOK 458 million. Profit before tax and fair-value adjustments came to NOK 95.3 million. The net loss for the period came to NOK 170.1 million after negative fair-value adjustments of investment properties and interest-rate-derivatives. That meant second-quarter earnings per share (EPS) were negative at NOK 0.34. Carried equity per share at 30 June 2020 was NOK 16.06, down from NOK 16.41 at 31 March. CEO Bent

Ferronordic strengthens its management team

Ferronordic has appointed Ceren Wende Director of Marketing and Communications as of 3 AugustCeren Wende has a broad international experience of marketing and communication from roles in Ogilvy, Reuters and Siemens. Since 2015, Ceren has worked with marketing and communication in leading positions in Volvo Trucks with a special focus on developing the Group’s digital marketing strategy. She has a Master's degree in Politics and Social and Economic History from the University of Edinburgh. Ceren will report directly to Ferronordic’s CEO, Lars Corneliusson. Lars Corneliusson, comments: ”I

Further clinical implementation of deep learning segmentation in treatment planning system RayStation takes place at Leeds Cancer Centre

RaySearch Laboratories AB (publ) announces that its advanced deep learning segmentation functionality for lung delineation in breast radiation therapy has been carried out using treatment planning system RayStation® * at Leeds Cancer Centre (LCC) in the UK. Clinicians at LCC have successfully implemented the deep learning segmentation thorax solution available in RayStation following thorough investigation of the geometric and dosimetric accuracy of the generated organs-at-risk structures. Reference contours and deep learning segmentation contours were produced for 10 patients,

Ocean Yield ASA: Second quarter and first half year results 2020

Fornebu, 9[th] July 2020, Ocean Yield ASA (“Ocean Yield” or the “Company”) announces results for the second quarter and first half year ending 30[th] June 2020.Highlights · The Board of Directors has declared a dividend of USD 0.05 per share. This is the 28th consecutive quarterly dividend declared by the Company.  · EBITDA for Q2 2020 was USD 86.3 million. This includes USD 27.4 million of revenue related to the vessel Höegh Xiamen, as further described below. EBITDA adjusted for finance lease effects and excluding the revenue related to the Höegh Xiamen was USD 86.0 million.

Mycronic US operations combined in new state-of-the-art facility near Boston

Mycronic US is pleased to announce that all of its operations have been successfully integrated into a new state-of-the-art, 102,000 square-foot facility in Tewksbury, near Boston, Massachusetts. This brings together under one roof the Global Technologies division comprising of MRSI Systems and AEi and the US operations of Mycronic’s High Flex division.The combined facility will help Mycronic better meet the requirements of future growth, customer needs and enable a stronger Mycronic identity in the US. The new building contains newly renovated office spaces, production areas, extensive

PROVENTUS CAPITAL ANNOUNCES NAV OF PROVENTUS CAPITAL PARTNERS IV

Press release   Stockholm, 9 July 2020 Proventus Capital today announces that, at the close of business on 30 June 2020, the Net Asset Value per participation loan debentures of Proventus Capital Partners IV, is EUR 106.84 for series A1. Ordinary Income of EUR 1.87 per series A1 participation loan debentures will be distributed to debenture holders on 21 July 2020. No repayment of capital will be distributed to the debenture holders for the quarter. Proventus Capital Partners IV’s assets are composed of 79 per cent privately issued corporate loans and 21 per cent publicly

PROVENTUS CAPITAL ANNOUNCES NAV OF PROVENTUS CAPITAL PARTNERS IV B

Press release Stockholm, 9 July 2020 Proventus Capital today announces that, at the close of business on 30 June 2020, the Net Asset Value per participation loan debentures of Proventus Capital Partners IV B, is EUR 104.84 for series A1 and EUR 1,052.99 for series B. Ordinary Income of EUR 0.87 per series A1 participation loan debentures and EUR 15.7 per series B participation loan debenture will be distributed on 21 July 2020. No repayment of capital will be distributed to our debenture holders for the quarter. Proventus Capital Partners IV B’s assets are composed of 79 per

Dignitana selected as Scalp Cooling Provider by Nuffield Health in UK

Next generation DigniCap Delta device minimizes hair loss from chemotherapyDignitana AB  today announces a partnership with Nuffield Health  in the United Kingdom to provide DigniCap scalp cooling to minimize hair loss from chemotherapy. As the largest healthcare charity in the United Kingdom, Nuffield Health operates 31 hospitals and will initially provide DigniCap at North Staffordshire in Newcastle-under-Lyme and Wolverhampton Hospital in West Midlands, expanding to other Nuffield

Completion of SBB's sale of properties for SEK 4.9bn to Nyfosa takes place today

As previously announced, on 10 June 2020, Samhällsbyggnadsbolaget i Norden AB (publ) (“SBB”) signed an agreement for the sale of office properties totalling SEK 4.9bn to Nyfosa AB (“Nyfosa”). The transaction was conditional upon financing and approval from the Swedish Competition Authority (the “Competition Authority”). On 30 June 2020, Nyfosa announced that the financing condition had been resolved, and the Competition Authority has now announced a positive clearance. Hence, the transaction can be completed and  closing will take place today. “This sale is an important component in our

Nyfosa completes acquisition of property portfolio for SEK 4.9 billion

As previously announced, on June 10, 2020, Nyfosa signed an agreement to acquire from SBB i Norden AB a property portfolio with primarily tax-financed tenants at a value of SEK 4.9 billion. The Swedish Competition Authority has given its approval of the transaction and the acquisition has thus been completed with access today. The deal adds stable cash flows and is another step in Nyfosa’s growth – the company’s property portfolio has increased by 50 percent this year.The properties have a total annual rental value of approximately SEK 402 million, of which 79 percent is derived from tax-

There are no items matching the current filter
There are no more items matching the current filter
Back to top